银屑病关节炎附着点炎(第三部分):临床评估与管理
本文聚焦银屑病关节炎(PsA)附着点炎的体格检查评估、对功能和生活质量的影响、合并纤维肌痛(FM)对临床评估的干扰,以及生物制剂和靶向合成DMARDs治疗附着点炎的临床试验证据。多种体格检查方法可靠,附着点炎显著损害功能和生活质量,合并FM可能干扰疾病严重度评估并阻碍达标治疗,多类靶向治疗显示显著疗效。
要点
- 多种附着点炎体格检查方法已证实可靠,可用于临床评估。
- 附着点炎对患者功能和生活质量有显著不良影响。
- 合并FM可干扰疾病活动度评估并阻碍低疾病活动度或缓解的达成。
核心结论
- 附着点炎是PsA常见临床特征,多种靶向治疗对其显示出显著疗效并改善功能和生活质量。
- 合并FM可能干扰附着点炎和疾病严重度的临床评估,并阻碍达标治疗目标的实现。
研究设计与样本
- 本文为综述,聚焦附着点炎的体格检查评估、对功能和生活质量的影响、合并FM的影响及靶向治疗证据。
主要发现
- 多种附着点炎体格检查方法已开发并证实可靠。
- 附着点炎对功能和生活质量有显著不良影响。
- 合并FM的患者比例≤20%,可能导致疾病严重度评估假性恶化并阻碍低疾病活动度或缓解的达成。
- 靶向TNF、IL-17、IL-23、磷酸二酯酶4或Janus激酶通路的多种靶向治疗对附着点炎显示出显著疗效,改善PsA患者功能和生活质量。
临床怎么用
- 临床应采用可靠的体格检查方法评估附着点炎。
- 应关注合并FM对疾病活动度评估的干扰,避免假性恶化影响达标治疗决策。
- 靶向TNF、IL-17、IL-23、PDE4或JAK通路的治疗可用于改善附着点炎及患者功能和生活质量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Enthesitis is a common clinical feature of PsA, which is characterized by inflammation at the site of insertion of tendons, ligaments and joint capsule fibres into bone. Enthesitis is relatively unique to the spondyloarthritides, setting this group of diseases apart from other rheumatological conditions. The pathophysiological underpinnings of this clinical domain, and the imaging assessment of it, are described in accompanying articles in this supplement. The focus of this article is on the assessment of enthesitis by physical examination, the impact of enthesitis on function and quality of life, the impact of concomitant FM on clinical assessment, and the evidence for therapy of enthesitis garnered in trials of biologic and targeted synthetic DMARDs. Several physical examination measures of enthesitis have been developed and have proved reliable in assessment of enthesitis. Enthesitis has a significant deleterious impact on function and quality of life. The presence of concomitant FM in ≤20% of patients may result in artefactual worsening of assessment of disease severity and hinder achievement of the goal of low disease activity or remission. Several targeted therapies, which, for example, target the TNF, IL-17, IL-23, phosphodiesterase 4 or Janus kinase pathways, have shown significant efficacy in the treatment of enthesitis, resulting in improvement of function and quality of life for patients with PsA.
引用
- Mease P. Enthesitis in psoriatic arthritis (Part 3): clinical assessment and management. Rheumatology (Oxford). 2020. PMID: 32159795. doi:10.1093/rheumatology/keaa042
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。